Terray Therapeutics
CA - MonroviaBiotechnology
Focus: Terray Therapeutics is a platform-driven biotech company leveraging spatially encoded screening and optimization technology to discover novel therapeutics. The company operates as a pre-revenue biotech focused on ophthalmology and immunology indications.
Profile data last refreshed 9h ago · AI intelligence enriched 2w ago
Open Jobs
6+2 this month
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
Should You Work at Terray Therapeutics?
AI assessmentTerray is a high-risk, high-potential-upside early-stage platform play suitable only for scientists willing to trade stability for equity upside and technical differentiation.
Why Work Here
- Opportunity to work on proprietary spatially encoded screening platform with differentiated drug discovery approach in growing therapeutic areas
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Terray Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.